Thyroid function and all-cause mortality in the context of multimorbidity: results from two population-based studies.

Yanning Xu, Silvan Licher, W Edward Visser, Stephan J L Bakker, Robin Peeters, Robin P F Dullaart, Layal Chaker
{"title":"Thyroid function and all-cause mortality in the context of multimorbidity: results from two population-based studies.","authors":"Yanning Xu, Silvan Licher, W Edward Visser, Stephan J L Bakker, Robin Peeters, Robin P F Dullaart, Layal Chaker","doi":"10.1210/clinem/dgaf425","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Thyroid dysfunction is common in aging populations and associated with increased non-communicable disease risk. Complex disease interactions in multimorbidity may influence this association. We aimed to examine the association between thyroid function and all-cause mortality in the context of multimorbidity.</p><p><strong>Methods: </strong>We included participants with thyroid function measurements and recorded disease status from the PREVEND and the Rotterdam studies and categorized them into three groups (no disease, one disease and multimorbidity). We utilized cox-proportional hazards models for the associations between thyroid function and all-cause mortality. Hazard ratios (HRs) were expressed per one unit increment in thyroid function Z-scores.</p><p><strong>Results: </strong>5537 participants (mean age 53.0 years) from PREVEND and 9080 participants (mean age 64.9 years) from the Rotterdam Study were included. Higher FT4 concentrations were associated with a higher all-cause mortality risk in the Rotterdam Study, with HRs per 1 unit increase in Z-score of 1.07 (1.03-1.12), 1.09 (1.04-1.15), 1.21 (1.11-1.31) for individuals with no disease, one disease, and multimorbidity respectively (p for trend<0.001), while a similar but non-significant trend was observed in PREVEND. We show a lower mortality risk for higher FT3 concentrations among individuals with one disease (HR per 1 unit increase in Z-sore: 0.82, 0.70-0.97) and multimorbidity (HR 0.80, 0.61-1.05) (p for trend=0.002).</p><p><strong>Conclusion: </strong>We show an association between higher FT4 and mortality for individuals with multimorbidity, while lower FT3 was associated with poor survival in individuals with multimorbidity. Our results extend findings from patient populations to people with multimorbidity from the general population. Future research is needed to investigate whether these findings extend to levothyroxine users.</p>","PeriodicalId":520805,"journal":{"name":"The Journal of clinical endocrinology and metabolism","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of clinical endocrinology and metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/clinem/dgaf425","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Thyroid dysfunction is common in aging populations and associated with increased non-communicable disease risk. Complex disease interactions in multimorbidity may influence this association. We aimed to examine the association between thyroid function and all-cause mortality in the context of multimorbidity.

Methods: We included participants with thyroid function measurements and recorded disease status from the PREVEND and the Rotterdam studies and categorized them into three groups (no disease, one disease and multimorbidity). We utilized cox-proportional hazards models for the associations between thyroid function and all-cause mortality. Hazard ratios (HRs) were expressed per one unit increment in thyroid function Z-scores.

Results: 5537 participants (mean age 53.0 years) from PREVEND and 9080 participants (mean age 64.9 years) from the Rotterdam Study were included. Higher FT4 concentrations were associated with a higher all-cause mortality risk in the Rotterdam Study, with HRs per 1 unit increase in Z-score of 1.07 (1.03-1.12), 1.09 (1.04-1.15), 1.21 (1.11-1.31) for individuals with no disease, one disease, and multimorbidity respectively (p for trend<0.001), while a similar but non-significant trend was observed in PREVEND. We show a lower mortality risk for higher FT3 concentrations among individuals with one disease (HR per 1 unit increase in Z-sore: 0.82, 0.70-0.97) and multimorbidity (HR 0.80, 0.61-1.05) (p for trend=0.002).

Conclusion: We show an association between higher FT4 and mortality for individuals with multimorbidity, while lower FT3 was associated with poor survival in individuals with multimorbidity. Our results extend findings from patient populations to people with multimorbidity from the general population. Future research is needed to investigate whether these findings extend to levothyroxine users.

多病背景下的甲状腺功能和全因死亡率:两项基于人群的研究结果
背景:甲状腺功能障碍在老年人群中很常见,并与非传染性疾病风险增加有关。多重发病的复杂疾病相互作用可能影响这种关联。我们的目的是在多重发病的背景下研究甲状腺功能和全因死亡率之间的关系。方法:我们纳入了来自PREVEND和Rotterdam研究的甲状腺功能测量和记录疾病状态的参与者,并将他们分为三组(无疾病、一种疾病和多疾病)。我们使用cox-proportional风险模型来分析甲状腺功能和全因死亡率之间的关系。风险比(hr)以甲状腺功能z评分每增加一个单位表示。结果:包括来自PREVEND的5537名参与者(平均年龄53.0岁)和来自鹿特丹研究的9080名参与者(平均年龄64.9岁)。在鹿特丹研究中,较高的FT4浓度与较高的全因死亡风险相关,无疾病、单一疾病和多重疾病个体的Z-score每单位增加的hr分别为1.07(1.03-1.12)、1.09(1.04-1.15)、1.21 (1.11-1.31)(p表示趋势)。结论:我们显示多重疾病个体的高FT4与死亡率之间存在关联,而低FT3与多重疾病个体的低生存率相关。我们的研究结果将研究范围从患者人群扩展到普通人群中的多病人群。未来的研究需要调查这些发现是否适用于左甲状腺素使用者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信